Status: Recruiting
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
The purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.
Participants needed: 50
Trial details
Phase: Phase 4Age: 20-40Biological sex: FemaleType: InterventionalSponsor: First People's Hospital of HangzhouUpdated: Sep 8, 2025Locations: 1
Eligibility criteria
Age of 20-40 years; Positive for hepatitis B surface antigen (HBsAg) and hepatit...
Co-infected with hepatitis C or HIV, or other chronic diseases; History of spont...